Evidence for eIF2α phosphorylation-independent effects of GSK2656157, a novel catalytic inhibitor of PERK with clinical implications.
| Autor: | Krishnamoorthy, Jothilatha, Rajesh, Kamindla, Mirzajani, Farzaneh, Kesoglidou, Polixenia, Papadakis, Andreas I., Koromilas, Antonis E. |
|---|---|
| Zdroj: | Cell Cycle; 3/1/2014, Vol. 13 Issue 5, p801-806, 6p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|